Aptamer Group PLC, together with its subsidiaries, provides synthetic binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally. The company offers Optimer, a platform that enables the discovery and development of optimized DNA ... Aptamer Group PLC, together with its subsidiaries, provides synthetic binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally. The company offers Optimer, a platform that enables the discovery and development of optimized DNA and RNA aptamers, which can bind to target molecules. Its platform is used in research reagent and analytical, bioprocessing, diagnostic, cosmetic and consumer health, and therapeutic applications. The company serves pharmaceutical, diagnostic, and bioprocessing companies. It has collaborations with Unilever, Neuro-Bio, the University of Glasgow, AstraZeneca, and Invizius. Aptamer Group PLC was founded in 2008 and is headquartered in York, the United Kingdom. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0.525 | 0.55 | 0.525 | 2593529 | 0.525 | DE |
| 4 | -0.05 | -8.69565217391 | 0.575 | 0.575 | 0.525 | 2551335 | 0.54412343 | DE |
| 12 | -0.225 | -30 | 0.75 | 0.75 | 0.525 | 5093243 | 0.60426886 | DE |
| 26 | -0.275 | -34.375 | 0.8 | 1.1 | 0.525 | 5164862 | 0.76518535 | DE |
| 52 | 0.195 | 59.0909090909 | 0.33 | 1.525 | 0.315 | 11694542 | 0.75700941 | DE |
| 156 | -8.475 | -94.1666666667 | 9 | 30.5 | 0.205 | 10915754 | 0.63621218 | DE |
| 260 | -127.975 | -99.5914396887 | 128.5 | 153 | 0.205 | 7392320 | 0.65854007 | DE |
DeerBalls
6分前
newbe2investing
8分前
Myth
12分前
Hey_Its_That_Guy
13分前
boytroy88
15分前
peafunke
16分前
Guido2
20分前
boston745
21分前
Guido2
24分前
Cynmark24
27分前
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。